The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh

被引:6
作者
Teerawattananon, Yot [1 ]
Tantivess, Sripen [1 ]
Yamabhai, Inthira [1 ]
Tritasavit, Nattha [1 ]
Walker, Damian G. [2 ]
Cohen, Joshua T. [3 ]
Neumann, Peter J. [3 ]
机构
[1] Minist Publ Hlth, Hlth Intervent & Technol Assessment Program, Nonthaburi, Thailand
[2] Bill & Melinda Gates Fdn, Seattle, WA USA
[3] Tufts Univ, Tufts Med Ctr, Boston, MA 02111 USA
关键词
Cost per DALY; Economic evaluation; Registry; Database; Policy decisions; Low- and middle-income countries; CARE DECISION-MAKING; ECONOMIC-EVALUATION; COVERAGE; FUTURE;
D O I
10.1186/s12961-016-0156-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low-and middle-income countries (LMICs) that include limited stakeholder awareness, resources and data availability, as well as the lack of capacity to conduct country-specific economic evaluations. This study aims to survey health policy experts' opinions on barriers to use of cost-effectiveness data in these settings and to obtain their advice on how to make a new cost-per-DALY database being developed by Tufts Medical Center more relevant to LMICs. It also identifies the factors influencing transferability. Methods: In-depth interviews were conducted with 32 participants, including policymakers, technical advisors, and researchers in Health Ministries, universities and non-governmental organisations in Bangladesh, India (New Delhi, Tamil Nadu and Karnataka) and Vietnam. Results: The survey revealed that, in all settings, the use of cost-effectiveness information in policy development is lacking, owing to limited knowledge among policymakers and inadequate human resources with health economics expertise in the government sector. Furthermore, researchers in universities do not have close connections with health authorities. In India and Vietnam, the demand for evidence to inform coverage decisions tends to increase as the countries are moving towards universal health coverage. The informants in all countries argue that cost-effectiveness data are useful for decision-makers; however, most of them do not perform data searches by themselves but rely on the information provided by the technical advisor counterparts. Most interviewees were familiar with using evidence from other countries and were also aware of the influences of contextual elements as a limitation of transferability. Finally, strategies to promote the newly developed database include training on basic economic evaluation for policymakers and researchers, and effective communication programs, with support from reputable global agencies. Conclusions: Although cost-effectiveness information is recognised as essential in resource allocation, there are several impediments in the generation and use of such evidence to inform priority setting in LMICs. As such, the Cost-per-DALY database should be well-designed and introduced with appropriate promotion strategies so that it will be helpful in real-world policymaking.
引用
收藏
页数:10
相关论文
共 29 条
[1]   Innovation for universal health coverage in Bangladesh: a call to action [J].
Adams, Alayne M. ;
Ahmed, Tanvir ;
El Arifeen, Shams ;
Evans, Timothy G. ;
Huda, Tanvir ;
Reichenbach, Laura .
LANCET, 2013, 382 (9910) :2104-2111
[2]   ADJUSTING LIFE FOR QUALITY OR DISABILITY: STYLISTIC DIFFERENCE OR SUBSTANTIAL DISPUTE? [J].
Airoldi, Mara ;
Morton, Alec .
HEALTH ECONOMICS, 2009, 18 (11) :1237-1247
[3]   Priority setting for pharmaceuticals: The use of health economic evidence by reimbursement and clinical guidance committees [J].
Anell A. .
The European Journal of Health Economics, formerly: HEPAC , 2004, 5 (1) :28-35
[4]  
[Anonymous], BANGL STAT SUMM
[5]  
[Anonymous], CHOOSING INT AR COST
[6]  
[Anonymous], 2014, DAT VIS
[7]  
[Anonymous], 2014, Data and Statistics
[8]   The value of DALY life: problems with ethics and validity of disability adjusted life years [J].
Arnesen, T ;
Nord, E .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7222) :1423-1425
[9]   Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening [J].
Balabanova, Dina ;
Mills, Anne ;
Conteh, Lesong ;
Akkazieva, Baktygul ;
Banteyerga, Hailom ;
Dash, Umakant ;
Gilson, Lucy ;
Harmer, Andrew ;
Ibraimova, Ainura ;
Islam, Ziaul ;
Kidanu, Aklilu ;
Koehlmoos, Tracey P. ;
Limwattananon, Supon ;
Muraleedharan, V. R. ;
Murzalieva, Gulgun ;
Palafox, Benjamin ;
Panichkriangkrai, Warisa ;
Patcharanarumol, Walaiporn ;
Penn-Kekana, Loveday ;
Powell-Jackson, Timothy ;
Tangcharoensathien, Viroj ;
McKee, Martin .
LANCET, 2013, 381 (9883) :2118-2133
[10]   The Current Capacity and Future Development of Economic Evaluation for Policy Decision-Making: A Survey among Researchers and Decision-Makers in Thailand [J].
Chaikledkaew, Usa ;
Lertpitakpong, Chanida ;
Teerawattananon, Yot ;
Thavorncharoensap, Montarat ;
Tangcharoensathien, Viroj .
VALUE IN HEALTH, 2009, 12 :S31-S35